NDC 71656-072 – Lithium
Lithium Citrate 8 meq/5mL · Solution · Oral
Product NDC71656-072
Product details
- Brand name
- Lithium
- Generic name
- Lithium
- Labeler
- Saptalis Pharmaceuticals, LLC
- Dosage form
- Solution
- Route
- Oral
- Marketing category
- ANDA · ANDA217183
- Marketed since
- March 28, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Mood Stabilizer
Active ingredients
- Lithium Citrate 8 meq/5mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 71656-072-16 | 473 mL in 1 BOTTLE (71656-072-16) | Apr 5, 2024 |
| 71656-072-50 | 5 TRAY in 1 CASE (71656-072-50) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (71656-072-05) | Mar 28, 2024 |
Other Lithium products
- 72888-172 Lithium Citrate 8 meq/5mL · Solution · Advagen Pharma Ltd
- 17856-1172 Lithium Citrate 8 meq/5mL · Solution · Atlantic Biologicals Corp.
- 0121-1027 Lithium Citrate 8 meq/5mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 0121-4027 Lithium Citrate 8 meq/5mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 68094-077 Lithium Citrate 8 meq/5mL · Solution · Precision Dose, Inc.
- 70518-4227 Lithium Citrate 8 meq/5mL · Solution · REMEDYREPACK INC.
- 60986-1019 Lithium Bromide 3 [hp_X]/mL · Liquid · Marco Pharma International LLC.